2025/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2024/06 USD(K$) | 2023/06 USD(K$) | 2022/06 USD(K$) | 2021/06 USD(K$) | |
Insurance Revenue | 5,326,000 | 7.357% | 4,961,000 | 4,591,000 | -- | -- |
Interest Income | 1,686,000 | 7.732% | 1,565,000 | -- | -- | -- |
Turnover | -- | -- | -- | -- | -- | -- |
Gross Premium Income | -- | -- | -- | -- | 4,159,000 | 11,521,000 |
Net Premium Income | -- | -- | -- | -- | 4,137,000 | 10,623,000 |
Investment Income/(Loss) | 5,373,000 | 477.742% | 930,000 | 7,171,000 | (2,098,000) | 738,000 |
Net Realised Gains/(Losses) on Assets | -- | -- | -- | -- | -- | -- |
Net Fair Value Gains / (Losses) on Assets | -- | -- | -- | -- | -- | -- |
Other Income/(Loss) | 189,000 | -4.061% | 197,000 | 176,000 | 204,000 | 331,000 |
Total Revenues | 12,574,000 | 64.302% | 7,653,000 | 11,938,000 | 2,243,000 | 11,692,000 |
Insurance Service Expenses | (3,961,000) | 8.879% | (3,638,000) | (3,489,000) | -- | -- |
Net Expenses from Reinsurance Contracts | (125,000) | -50.397% | (252,000) | (83,000) | -- | -- |
Net Finance (Expenses)/Income from Insurance Contracts | (6,149,000) | 170.405% | (2,274,000) | -- | -- | -- |
Net Finance (Expenses)/Income from Reinsurance Contracts | -- | -- | -- | (6,496,000) | -- | -- |
Net Impairment Loss | -- | -- | -- | -- | -- | -- |
Other Expenses | (604,000) | -18.378% | (740,000) | (554,000) | (3,512,000) | (10,370,000) |
Other Non-operating Items | -- | -- | -- | -- | -- | 0 |
Share of results of Associates & JCEs | (28,000) | -88.477% | (243,000) | (73,000) | (54,000) | 179,000 |
Profit / (Loss) before Taxation | 1,707,000 | 237.352% | 506,000 | 1,243,000 | (1,323,000) | 1,501,000 |
Taxation | (348,000) | 7.407% | (324,000) | (296,000) | (182,000) | (431,000) |
Profit / (Loss) for Discontinued Operations | -- | -- | -- | -- | -- | (5,707,000) |
Non-controlling Interests | (75,000) | 20.968% | (62,000) | (3,000) | (3,000) | 627,000 |
Others | -- | -- | -- | -- | -- | -- |
Profit/ (Loss) Attributable to Shareholders | 1,284,000 | 970.000% | 120,000 | 944,000 | (1,508,000) | (4,010,000) |
2025/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2024/06 USD(K$) | 2023/06 USD(K$) | 2022/06 USD(K$) | 2021/06 USD(K$) | |
Depreciation & Amortisation | -- | -- | -- | -- | -- | -- |
Directors' Emoluments | -- | -- | -- | -- | -- | -- |
2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
EPS (cts) | 49.200 | 1018.182% | 4.400 | 34.500 | 55.100 | -154.200 |
DPS (cts) | 7.710 | -- | 6.840 | 6.260 | 5.740 | 5.370 |
Dividend Payout Ratio (%) | 15.671% | -- | 155.455% | 18.145% | 10.417% | -- |
Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
NBV per share ($) | 7.009 | -- | 5.884 | 6.232 | 5.859 | 6.007 |
Remarks: | Real time quote last updated: 08/09/2025 17:59 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
Profit / (Loss) Attributable to Shareholders (K$) | USD 1,284,000 |
%Change | 970.000% |
EPS / (LPS) | USD 0.492 |
NBV Per Share ($) | USD 7.009 |